I find it revealing that the development of Chidamide in China, even with ''China’s cumbersome rules for drug approval'' was estimated to be 10 times cheaper than to develop in the US, according to Dr Lu. The article brought up this point on multiple occasions. If the US has major problems in regards to the expense of healthcare, perhaps multiple solutions could be evaluated by Congress, instead of recent developments?
I find the research on cancer and biomedicine to be fascinating, and there are multiple recent trail blazing developments in the field in regards to curing cancer by 'highlighting' so the immune system can fight and easily subsume cancer cells.
No comments:
Post a Comment